Providers/Grant Support
This activity is supported by an independent educational grant from Merck KGaA, Darmstadt, Germany and UCB Inc.
Credits Available
- Physicians — maximum of 0.5 AMA PRA Category 1 Credits™
All other healthcare professionals completing this course will be issued a statement of participation.
Target Audience
This activity is designed to meet the educational needs of clinicians and nurse practitioners within the neurology, neuromuscular, or neuroimmunology disease space.
Program Overview
In this patient-physician conversation, Janel Worcester-Brown and Dr. Kelly Gwathmey, MD, engage in compelling and candid discussion of the realities of living with generalized myasthenia gravis (gMG) and the challenges patients face navigating their healthcare journey.
Together, they reveal real-world patient perspectives combined with expert provider insights, to uncover the lived experiences of patients with gMG, the unmet needs and gaps in care, and how embracing a patient-centric approach and shared decision-making can make a difference.
Join Janel and Kelly in the interactive video module and take the next step in shaping more meaningful care for your patients.
---
This conversation is available as a transcript to download.
This activity is part of the larger CME-accredited program, Awareness Advances Action: Optimizing Outcomes for Patients with gMG . Register for free to access the expert-led gMG Disease Dialogues video podcast series or put your knowledge into action with your very own ready-to-use toolkit of patient education guides and clinical resources.
© 2025 Springer Healthcare LLC. Springer Health+ IME is part of Springer Nature. All rights reserved.
Learning Objectives
Upon completion of this activity, participants should be better able to:
- Discuss the challenges faced by patients with gMG and the importance of considering patient-reported outcomes (PROs) when evaluating treatment success.
Faculty
Dr. Kelly Gwathmey, MD – Program Director
Virginia Commonwealth University, Richmond, VA, United States
Kelly Gwathmey is originally from Richmond, Virginia. She studied neuroscience and behavioral biology at Emory University in Atlanta, Georgia. She then attended Eastern Virginia Medical School in Norfolk, Virginia. Her neurology and clinical neurophysiology training was completed at the University of Virginia. Following this, she completed a neuromuscular medicine fellowship at both Brigham and Women’s Hospital and Massachusetts General Hospital in Boston, Massachusetts. At the University of Virginia, she started the multidisciplinary MDA clinic, was co-director of the ALS clinic, and was the fellowship director for both the neuromuscular and clinical neurophysiology fellowships. She joined Virginia Commonwealth University in January 2019 and currently serves in the capacity of associate professor of neurology, neuromuscular division chair, neuromuscular medicine program director, and EMG laboratory director. Dr. Gwathmey sees a wide spectrum of neuromuscular patients and performs electrodiagnostic studies (nerve conduction studies and electromyography). Her research interests include quality-of-life instruments and autoimmune neuromuscular disorders.
Janel Worcester-Brown – Patient Contributor
Meet Janel Worcester-Brown. Janel spent her social-work career of over 20 years supporting and advocating for children and families. She was diagnosed with gMG in 2019. Since then, she has pivoted her advocacy passion to supporting patients living with chronic illness. She enjoys spending time with her understanding husband and is unbelievably proud of her two adult children. Janel is enthusiastic about being creative with textiles and painting, gardening …and on a good day, cooking. Her favorite place to be is in the peaceful Maine woods.
Accreditation Statement
In support of improving patient care, these activities have been planned and implemented by the Postgraduate Institute for Medicine and Springer Health+ IME. The Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit Designation
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.5 AMA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
Disclosures of Conflicts of Interest
Dr Kelly Gwathmey:
- Speakers Bureau/honoraria for non-CME: Alexion pharmaceuticals, argenx
- Consultant/advisory board: Alexion pharmaceuticals, Amgen, argenx, UCB
Janel Worcestor-Brown: None to disclose
Instructions for Participation and Credit
There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:
- Read the CME/CE information and faculty disclosures.
- Participate in the online activity.
- Submit the evaluation form.
Certificates will be immediately available for the participant.
Disclosure of Unlabeled Use
Faculty participating in any CME activity are required to disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
Disclaimer
This activity is designed for educational purposes for healthcare professionals only. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
Contact Information
For CME questions please contact: [email protected].